Identification of actionable targets in chromophobe renal cell carcinoma detected by multiplatform molecular analysis


Philip Abbosh1, Sherri Z. Millis2, Nancy Doll2, Adam Hauben2, Sandeep Reddy2, Daniel M. Geynisman1, Robert Uzzo1

Chromophobe renal cell carcinoma (chRCC) is rare and infrequently metastasizes or recurs after definitive local therapy. We performed multiplatform tumor profiling to identify potentially druggable targets in chRCC.

Download Publication